Biogen Inc (NASDAQ:BIIB) over-valued by 10%
Website | https://www.biogen.com/ |
Sector | Healthcare |
Industry | Drug Manufacturers General |
Fiscal Year End | Dec 31, 2021 |
Market Cap | $42,418,872,320 |
Beta | 0.436845 |
Average Volume | $1,088,167 |
Last Dividend | 0% |
Price on Feb 3, 2022 | $226.81 |
Autochartist™ Valuation | $203.47 |
Conclusion |
10% over-valued |
Download Report |